BACKGROUND: Hepatocyte growth factor (HGF) can promote proliferation, invasion, and angiogenesis in various tumor cells. However, the prognosis according to expression of HGF/c-Met has not been reported in patients with squamous cell carcinoma of the oral tongue (SCCOT). METHODS: Tumors from 61 patients with SCCOT were evaluated for the expression of HGF and c-Met by immunohistochemistry. For Western blot, we used fresh normal and cancer tissues from 3 patients with SCCOT. RESULTS: The positive rates of HGF and c-Met immunostaining in SCCOT were 57.3% and 54.1%, respectively. The c-Met staining was significantly correlated with lymph node metastasis (p = .005), tumor classification (p = .004), and recurrence (p = .018). Survival was significantly affected in patients with positive c-Met expression (p = .003). HGF and c-Met were strongly expressed in cancer tissues on Western blot. CONCLUSION: The c-Met expression may play an important role in the progression and the survival outcome of patients with SCCOT.
BACKGROUND:Hepatocyte growth factor (HGF) can promote proliferation, invasion, and angiogenesis in various tumor cells. However, the prognosis according to expression of HGF/c-Met has not been reported in patients with squamous cell carcinoma of the oral tongue (SCCOT). METHODS: Tumors from 61 patients with SCCOT were evaluated for the expression of HGF and c-Met by immunohistochemistry. For Western blot, we used fresh normal and cancer tissues from 3 patients with SCCOT. RESULTS: The positive rates of HGF and c-Met immunostaining in SCCOT were 57.3% and 54.1%, respectively. The c-Met staining was significantly correlated with lymph node metastasis (p = .005), tumor classification (p = .004), and recurrence (p = .018). Survival was significantly affected in patients with positive c-Met expression (p = .003). HGF and c-Met were strongly expressed in cancer tissues on Western blot. CONCLUSION: The c-Met expression may play an important role in the progression and the survival outcome of patients with SCCOT.
Authors: Lanea M Keller; Thomas J Galloway; Thomas Holdbrook; Karen Ruth; Donghua Yang; Cara Dubyk; Douglas Flieder; Miriam N Lango; Ranee Mehra; Barbara Burtness; John A Ridge Journal: Head Neck Date: 2014-01-13 Impact factor: 3.147
Authors: Ranee Mehra; Ilya G Serebriiskii; Roland L Dunbrack; Matthew K Robinson; Barbara Burtness; Erica A Golemis Journal: Drug Resist Updat Date: 2011-09-14 Impact factor: 18.500
Authors: H J Park; K Kim; J H Paik; E K Chie; S Kim; J-Y Jang; S W Kim; S-W Han; D-Y Oh; S-A Im; T-Y Kim; Y-J Bang; S W Ha Journal: Clin Transl Oncol Date: 2015-10-12 Impact factor: 3.405
Authors: E Arriola; I Cañadas; M Arumí-Uría; M Dómine; J A Lopez-Vilariño; O Arpí; M Salido; S Menéndez; E Grande; F R Hirsch; S Serrano; B Bellosillo; F Rojo; A Rovira; J Albanell Journal: Br J Cancer Date: 2011-08-16 Impact factor: 7.640
Authors: Byung Woog Kang; Jong Gwang Kim; Heyoung Park; Bo Eun Park; Seong Woo Jeon; Han Ik Bae; Oh-Kyoung Kwon; Ho Young Chung; Wansik Yu Journal: Chonnam Med J Date: 2015-08-17